Zinc monotherapy from time of diagnosis for young pediatric patients with presymptomatic Wilson disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 4, 2011, Pages 365-367

  Mizuochi, Tatsuki ^a   Kimura, Akihiko ^a   Shimizu, Norikazu ^b   Nishiura, Hiroshi ^a   Matsushita, Masami ^a   Yoshino, Makoto ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

liver function; presymptomatic Wilson disease; urinary copper excretion; zinc monotherapy

Indexed keywords

COPPER; ZINC ACETATE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHILD; CHILDHOOD DISEASE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG INTOXICATION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; IRON DEFICIENCY ANEMIA; LIVER FUNCTION; MAINTENANCE THERAPY; MONOTHERAPY; NAUSEA; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; URINE LEVEL; WILSON DISEASE;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; ASYMPTOMATIC DISEASES; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; FOLLOW-UP STUDIES; HEPATOLENTICULAR DEGENERATION; HUMANS; ZINC;

EID: 80053626556     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31821d5abe     Document Type: Article

References (10)

1. Brewer GJ. Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management. Boston: Kluwer Academic Publishers; 2001.
2. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XV. Long-term follow-up studies. J Lab Clin Med 1998; 132:264-78. (Pubitemid 28490259)
3. Marcellini M, Di Ciommo V, Callea F, et al. Treatment of Wilson's disease with zinc from the time of diagnosis in pediatric patients: A single-hospital, 10-year follow-up study. J Lab Clin Med 2005; 145:139-43. (Pubitemid 40432363)
4. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-42. (Pubitemid 37265785)
5. Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci 1987;77:137-46. (Pubitemid 17231288)
6. Wiggelinkhuizen M, Tilanus MEC, Bollen TC, et al. Systematic review: Clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease. Aliment Pharmacol Ther 2009;29:947-58.
7. Brewer GJ, Dick RD, Johnson VD, et al. Treatment of Wilson's disease with zinc: XVI. Treatment during the pediatric years. J Lab Clin Med 2001;137:191-8. (Pubitemid 32203199)
8. Wu ZY, Lin MT, Murong SX, et al. Molecular diagnosis and prophylactic therapy for presymptomatic Chinese patients withWilson disease. Arch Neurol 2003;60:737-41.
9. Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, et al. Treatment of Wilson's disease with zinc: XIII. Therapy with zinc in presymptomatic patients from the time of diagnosis. J Lab Clin Med 1994;123:849-58.
10. Linn FH, Houwen RH, van Hattum J, et al. Long-term exclusive zinc monotherapy in symptomaticWilson disease: Experience in 17 patients. Hepatology 2009;50:1442-52.